Bolt Technology Corporation consists of four operating units, such as Bolt Technology Corporation (Bolt), A-G Geophysical Products, Inc. (A-G), Real Time Systems Inc. (RTS) and SeaBotix Inc. (SBX). Each of these operating units is reported as a separate reportable segment for all periods presented in the Consolidated Financial Statements. The Company operates in four segments: seismic energy sources reportable segment (Bolt), underwater cables and connectors reportable segment (A-G), seismic energy source controllers reportable segment (RTS) and underwater robotic vehicles segment (SBX). The Company's Bolt, A-G and RTS products are used in marine seismic exploration surveys to acquire seismic data. Bolt develops, manufactures and sells marine seismic energy sources (air guns) and replacement parts. A-G develops, manufactures and sells underwater cables, connectors, hydrophones, depth and pressure transducers and seismic source monitoring systems.
Industry, Sector and Symbol
Stock Exchange NASDAQ
Industry N/A
Sub-IndustryOil & Gas Equipment & Services
SectorN/A
Current SymbolNASDAQ:BOLT
Previous Symbol
CUSIP09769810
WebN/A
PhoneN/A
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
EmployeesN/A
Outstanding SharesN/A
Market Cap$0.00
OptionableNot Optionable
BioLight Life Sciences (NASDAQ:BOLT) Frequently Asked Questions
What is BioLight Life Sciences' stock symbol?
BioLight Life Sciences trades on the NASDAQ under the ticker symbol "BOLT."
How were BioLight Life Sciences' earnings last quarter?
BioLight Life Sciences Ltd. (NASDAQ:BOLT) released its quarterly earnings results on Thursday, October, 23rd. The company reported ($0.07) earnings per share for the quarter. The firm had revenue of $11.90 million for the quarter, compared to analyst estimates of $16.20 million. View BioLight Life Sciences' Earnings History.
Has BioLight Life Sciences been receiving favorable news coverage?
Headlines about BOLT stock have trended very positive recently, InfoTrie reports. The research group identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. BioLight Life Sciences earned a news impact score of 3.6 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the next several days.
When did BioLight Life Sciences IPO?
(BOLT) raised $12 million in an initial public offering (IPO) on the week of March 14th 2016. The company issued 2,100,000 shares at a price of $4.60-$6.60 per share. Feltl and Company and Rodman & Renshaw a unit of H.C. Wainwright & Co. acted as the underwriters for the IPO.
How do I buy shares of BioLight Life Sciences?
Shares of BOLT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
MarketBeat Community Rating for BioLight Life Sciences (NASDAQ BOLT)
MarketBeat's community ratings are surveys of what our community members think about BioLight Life Sciences and other stocks. Vote "Outperform" if you believe BOLT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BOLT will underperform the S&P 500 over the long term. You may vote once every thirty days.
